Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Date

25 March 2021

Farmaceuten ontwikkelen bijna geen medicijnen voor kinderen

Karel Berkhout for Dutch news outlet NRC covers the latest paediatric finding from the 2021 Access to Medicine Index.

Referencing the latest finding on paediatric medicine development by pharmaceutical companies, the author notes that of the 1,100 drugs and vaccines being developed by pharma companies, only 69 are intended for children.

The article delves into the finding, quoting Access to Medicine Foundation Executive Director Jayasree K. Iyer to explain the reasons for the lack of paediatric medicines in pharma's pipeline. Jayasree comments on the impact of this disparity, offering examples of companies that are on the right track and pointing out where others can improve.

Read the full article here. 

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved